| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3997096 | Revista Colombiana de Cancerología | 2015 | 8 Pages |
Abstract
In this cohort it was found that patients with stage III melanoma receiving adjuvant interferon therapy had a lower relapse rate and better disease-free survival, which is in agreement with that reported in the literature.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mauricio GarcÃa, Sandra DÃaz, Angélica Gutiérrez, Jesús Sánchez, Ricardo Sánchez,